Dec
12
2022
New treatment for moderate to severe atopic dermatitis shows promising long-term results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab — a novel, patient-tailored monoclonal antibody therapy — showed promising results both while taking the...